Navigation Links
Amylin Pharmaceuticals Reports 2010 Financial Results
Date:1/26/2011

d-on therapy to basal insulin, with or without metformin and/or a TZD in conjunction with diet and exercise for adults with type 2 diabetes who are not achieving adequate glycemic control.
  • Lilly received approval of BYETTA in Canada for the treatment of adults with type 2 diabetes for use as a combination therapy with metformin and/or a sulfonylurea to improve blood sugar control in adults with type 2 diabetes who have not achieved adequate glycemic control on maximally tolerated doses of these oral therapies, in addition to diet and exercise.

  • Lipodystrophy Program

  • Submitted the initial sections of a rolling submission for a Biologics License Application (BLA) to the FDA for the use of metreleptin to treat diabetes and/or hypertriglyceridemia in patients with rare forms of lipodystrophy. The Company plans to submit the chemistry, manufacturing and controls (CMC) section of the BLA by the end of 2011, which will complete the submission.

  • Corporate

  • Announced research collaboration agreement with the Juvenile Diabetes Research Foundation to provide financial support for a clinical proof-of-concept study to investigate the effects of metreleptin, an analog of the human hormone leptin, in patients with type 1 diabetes.

  • Quarter Ended December 31, 2010Net product sales of $162.3 million for the quarter ended December 31, 2010 include U.S. sales of $136.4 million for BYETTA and $25.9 million for SYMLIN® (pramlintide acetate) injection. This compares to net product sales of $184.3 million, consisting of $163.7 million for BYETTA sales in the U.S. and $20.6 million for SYMLIN for the same period in 2009.

    Revenue under collaborative agreements was $11.9 million for the quarter ended December 31, 2010, compared to $1.3 million for the same period in 2009. In 2010, revenues under collaborative agreements consist of a $10.0 million milestone payment earned upon Lilly's December 2010 launch o
    '/>"/>

    SOURCE Amylin Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. Amylin Pharmaceuticals to Webcast Year-End Financial Results
    2. Amylin Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference
    3. Amylin Submits Clinical and Nonclinical Sections of Rolling Biologics License Application for Metreleptin to Treat Rare Forms of Lipodystrophy
    4. Amylin Pharmaceuticals Reports Third Quarter Financial Results
    5. Amylin Pharmaceuticals to Present at the 2010 Credit Suisse Healthcare Conference
    6. Amylin, Lilly and Alkermes Announce Receipt of Complete Response Letter from FDA for BYDUREON™
    7. Amylin Pharmaceuticals to Webcast Third Quarter Results
    8. Amylin Pharmaceuticals to Present at the Wedbush Life Sciences Conference 2010
    9. Amylin Pharmaceuticals Appoints Christian Weyer, MD Senior Vice President, Research and Development
    10. Amylin Pharmaceuticals to Present at The Barclays Capital 2010 Global Healthcare Conference
    11. Amylin and Takeda Announce Decision to Advance Development of Pramlintide/Metreleptin Combination Treatment for Obesity
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/18/2014)... Pharma IQ, after huge demand ... Countdown calendar to cover the years 2014 - 2018 ... shows the serialisation requirements around the globe and the ... For companies dealing with international markets, serialisation ... they will have to comply with new regulations coming ...
    (Date:9/18/2014)... 2014   3D Systems   (NYSE: DDD ... Mentor™ , a new robotic surgery skills and procedural training ... the ERUS exhibition in Amsterdam, The Netherlands ... Robotic-assisted minimally invasive surgery represents a growing portion of overall ... training for robotic surgery has increased, and it is expected ...
    (Date:9/18/2014)... 2014 After 6 months of careful ... here - the new programme for the next Cool Chain ... our global Cool Chain series, has just been released! ... As the lines between supply chain, logistics, QA and ... that is broad and yet specific, focused and yet accessible, ...
    Breaking Medicine Technology:Pharma IQ Displays Worldwide Serialisation Deadlines in their 2014 - 2018 Countdown Calendar 23D Systems Introduces New Simbionix Robotics Training Platform 23D Systems Introduces New Simbionix Robotics Training Platform 3Europe's Biggest and Longest-Running Gathering of Life Sciences Logistics, Supply Chain & QA Professionals 2
    ... , WASHINGTON, Nov. 24 ... and vaccines to treat or prevent HIV/AIDS and related conditions, according ... Manufacturers of America (PhRMA). December 1 marks the 21st anniversary of ... the 1988 World Summit of Ministers of Health on Programmes for ...
    ... , NORTH HOLLYWOOD, Calif., Nov. 24 ... national hospitalist physician group practice company, announced today that Philip Vaidyan, ... as one of the 2009 Top Ten Hospitalists in the ... magazine. , Dr. Vaidyan has been a practicing physician for more ...
    Cached Medicine Technology:New Report Shows 97 Medicines and Vaccines Currently in Development for HIV/AIDS 2New Report Shows 97 Medicines and Vaccines Currently in Development for HIV/AIDS 3IPC The Hospitalist Company's Philip Vaidyan, M.D. Named a Top Hospitalist of 2009 2IPC The Hospitalist Company's Philip Vaidyan, M.D. Named a Top Hospitalist of 2009 3
    (Date:9/18/2014)... effect of guidelines recommending that elderly men should not ... at best," according to a new study led by ... a research letter online in JAMA Internal Medicine ... antigen to test for prostate cancer., "We found ... routine screening of elderly men in particular has been ...
    (Date:9/18/2014)... develop tools that would allow them to clearly view ... neuron fires to the resulting behavior in a whole ... to develop a range of new tools to study ... tool that provides a new way of mapping neural ... between Viviana Gradinaru (BS ,05), assistant professor of biology ...
    (Date:9/18/2014)... September 18, 2014 With the swift ... of products such as smart phones, tablets and PDAs, ... the way mobile devices are viewed these days. From ... data to becoming a mode for creating and delivering ... a long way. , The complete makeover ...
    (Date:9/18/2014)... Technology Association of Georgia in collaboration ... TAG Social Savvy Awards this week at a special ... Center in Downtown Atlanta. The event celebrates Georgia’s best ... was honored with the 2014 TAG Social Savvy People’s ... innovators in 6 other award categories: , ...
    (Date:9/18/2014)... 18, 2014 A sold-out crowd of ... and volunteers supported United Way of Westchester and ... Fine Wines” event Monday, Sept. 15. Proceeds from the ... in Westchester and Putnam, such as providing healthy foods ... away from risky behaviors like drug and alcohol usage. ...
    Breaking Medicine News(10 mins):Health News:Professional recommendations against routine prostate cancer screening have little effect 2Health News:Sensing neuronal activity with light 2Health News:Sensing neuronal activity with light 3Health News:Sensing neuronal activity with light 4Health News:Sensing neuronal activity with light 5Health News:Transparency Market Research: M-health Market Study 2018 2Health News:Transparency Market Research: M-health Market Study 2018 3Health News:Transparency Market Research: M-health Market Study 2018 4Health News:Winners Honored at 2014 TAG Social Savvy Awards 2Health News:Winners Honored at 2014 TAG Social Savvy Awards 3Health News:United Way Celebrates “Best Chefs and Fine Wines” at Sold-Out Culinary Event 2Health News:United Way Celebrates “Best Chefs and Fine Wines” at Sold-Out Culinary Event 3
    ... Informed Medical Communications (IMC),a leading provider of peer-to-peer ... sale of its HealthTalk,division to Revolution Health Group. ... source of chronic care health information and interactive,programming ... The,announcement was made by IMC CEO Steven K. ...
    ... EDITOR,S PICK: Anticancer drugs might be of benefit to ... an inherited blood disorder caused by a genetic mutation ... of the beta-globin chain of hemoglobin (Hb). Red blood ... shape upon deoxygenation and this causes them to get ...
    ... the Country Appeal to the ... MRI, MALVERN, Pa., Dec. 6 For anyone who has ... find the time,now,s your chance to make a big impact on ... video posting period in Siemens first-ever,"Win an MRI" contest has closed. ...
    ... Limited (Neurochem), a wholly-owned subsidiary of Neurochem,Inc. (NASDAQ: ... Company has received an,acknowledgement from the United States ... the July 2007 approvable letter for the New,Drug ... of,Amyloid A (AA) amyloidosis is a complete, Class ...
    ... the American,Medical Women,s Association (AMWA) announced that Congressman ... his plan for health care reform,with thousands of ... on December 7., "As women and medical ... of health care is to our country and ...
    ... Jude Childrens Research Hospital scientists offers new insights into ... and could lead to new cancer treatments. , ... protein disposal, a finding that helps to explain how ... The discovery is important because the newly identified components ...
    Cached Medicine News:Health News:Informed Medical Communications Sells Consumer Internet Division to Revolution Health 2Health News:JCI online early table of contents: Dec. 6, 2007 2Health News:JCI online early table of contents: Dec. 6, 2007 3Health News:JCI online early table of contents: Dec. 6, 2007 4Health News:JCI online early table of contents: Dec. 6, 2007 5Health News:JCI online early table of contents: Dec. 6, 2007 6Health News:JCI online early table of contents: Dec. 6, 2007 7Health News:JCI online early table of contents: Dec. 6, 2007 8Health News:JCI online early table of contents: Dec. 6, 2007 9Health News:The Polls are Open! America Votes to Decide Which Hospital is the Most Deserving of Siemens' Newest MRI Technology 2Health News:The Polls are Open! America Votes to Decide Which Hospital is the Most Deserving of Siemens' Newest MRI Technology 3Health News:Neurochem announces eprodisate (KIACTA(TM)) receives acknowledgement of complete response and is granted Class 2 review 2Health News:Neurochem announces eprodisate (KIACTA(TM)) receives acknowledgement of complete response and is granted Class 2 review 3Health News:AMWA Hosts Health Care Conversation With Congressman Kucinich 2Health News:St. Jude finds mechanism for faulty protein disposal 2Health News:St. Jude finds mechanism for faulty protein disposal 3Health News:St. Jude finds mechanism for faulty protein disposal 4
    ... 1575 immunowash microplate washer ... needle position to perform ... maximize wash efficiency. This ... choice of wash that ...
    ... a solid made, manual plate washer ... for dispense and aspirate function ensure ... with a stand and all necessary ... used, as well as any bottles ...
    MW 96-W1 microplate washer with one wash line....
    Full automatic, ready-to-use strip washer....
    Medicine Products: